sr 48692 has been researched along with digitonin in 1 studies
Studies (sr 48692) | Trials (sr 48692) | Recent Studies (post-2010) (sr 48692) | Studies (digitonin) | Trials (digitonin) | Recent Studies (post-2010) (digitonin) |
---|---|---|---|---|---|
203 | 3 | 36 | 2,080 | 1 | 109 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Botto, JM; Chabry, J; Gully, D; Kitabgi, P; Labbé-Jullié, C; Maffrand, JP; Mas, MV; Mazella, J; Vincent, JP | 1 |
1 other study(ies) available for sr 48692 and digitonin
Article | Year |
---|---|
[3H]SR 48692, the first nonpeptide neurotensin antagonist radioligand: characterization of binding properties and evidence for distinct agonist and antagonist binding domains on the rat neurotensin receptor.
Topics: Animals; Binding Sites; Binding, Competitive; Cell Line; Digitonin; Guanosine 5'-O-(3-Thiotriphosphate); Kinetics; Mice; Mutation; Pyrazoles; Quinolines; Radioligand Assay; Rats; Receptors, Neurotensin; Sodium; Transfection | 1995 |